Minimum intervention oral healthcare delivery - is there consensus?
Minimum intervention oral healthcare delivery - is there consensus?"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Firstly, I'd like to take this opportunity to offer all _BDJ_ readers my sincere best wishes in what has been a trying 2020 so far. At the beginning of a new decade, heralded by many as
a fresh chance for humanity to embrace and nurture all that is positive in global and local society, we find ourselves having to re-adjust radically, both personally and professionally in
such unusual times, to a new 'norm' and there is still much to evolve in this regard. I have purposely avoided the over-used descriptor, 'unprecedented' to describe the
events that have transpired. Pandemics are not unprecedented. Indeed, they have and continue to affect humankind with a certain biological regularity over history. What is unprecedented is
the reaction of humankind. As society has begun the complex reactionary re-adjustment, it is clear that in the healthcare sector, many work practices and tenets of care delivery will be
forced to change. Positive opportunities need to be taken by all stakeholders in dentistry involved in delivering the best oral healthcare management to patients. These stakeholders include
the clinical/research profession, educators, the needs, wants and expectations of the public/patients, industry partners, service providers, indemnity associations and service regulators.
Therefore, this second minimum intervention (MI)-themed issue is in my opinion, quite timely in its planning, production and release. MI association with the _BDJ_ began in early 2012. An
informative series of MI-related papers in conservative dentistry had been published in a French journal, _Réalités Cliniques_, the previous year. I felt compelled to speak to my dear
friend, colleague and _BDJ_ editor-in-chief, Stephen Hancocks to see if these could be adapted and reprinted in the _BDJ_, so increasing their exposure to a wider audience. He agreed and hey
presto, in 2012 and 2013 in _BDJ_ volumes 213 and 214, they were published and proved to be of real interest and inspiration to the readership. Suitably enthused, in 2013, Stephen then
kindly invited me to author an editorial opinion piece introducing and outlining the concept of prevention-based minimum-intervention oral care (MIOC) provision and the challenges it might
face in gaining acceptance in the mainstream profession.1 The MIOC team-delivery framework is based around four interlinked domains, applicable to any of the restorative disciplines, across
all ages and patient groups (with suitable adaptions where necessary) (Figure 1): * Identifying problems (detection, risk/susceptibility assessment, diagnosis and patient-focused care
planning) * Prevention & control (primary, secondary and tertiary prevention of lesions, control of the disease process) * MI treatments/procedures (minimally invasive operative
management of carious/periodontal lesions, pulp pathology, broken-down or missing teeth) * Review/recall (reassessment of any treatment provided, patient behavioural adherence to change,
recall periodicity dependent on longitudinal susceptibility assessments).1 Four years later, I was again delighted and honoured this time to coordinate, co-author and present the first
MI-themed _BDJ_ issue as its guest editor, commissioning a selection of high quality manuscripts from national and international renowned professionals and dear colleagues with an
acknowledged expertise in MI dentistry.2 As can be seen from the range of papers published in that issue, alongside many other important publications in the dental literature, the clinical
academic evidence for MI dentistry is now far-reaching and more widely accepted as to be considered a mainstream approach in the profession and not solely for caries management as many still
perceive. The advances in clinical operative techniques/technologies/materials, behaviour management and another form of MI, motivational interviewing, are all enabling oral healthcare
teams to deliver successfully this contemporary approach to achieve and maintain oral health and long term wellbeing in our patients.3,4,5,6 However, even with such evidence laid bare, it is
clear that the uptake of minimally invasive operative principles/approaches, for example in caries management, is not universal in primary care practice.7,8 Therefore, it is timely that in
2020 this second MI-themed issue has been published, collating international experts' outputs on how the accepted principles of MIOC/minimally invasive operative dentistry (MID) can be
implemented in the broader world of 'real-life' primary care dentistry, for the benefit of our patients long term. This issue, which should be read and digested in conjunction with
the contents of the first MI-themed issue, focuses on clinical implementation strategies across the various disciplines of clinical dentistry that primary care practitioners and their teams
experience on a daily basis. One year ago, I gave the authors the brief to summarise knowledge and offer potential solutions/guidance for the use of MIOC principles to manage day-to-day
patients seen in a non-specialist, primary care setting. The clinical disciplines covered in this issue include, in no particular order, orthodontics, cariology (including detection
technologies, an update of restorative biomaterials and consensus guidelines of when to intervene in the caries process), periodontology, prosthodontics, paediatrics and the MI restorative
management of the anxious/phobic patient. The implementation challenges of MIOC across the world are discussed, using the US as a specific example. It is clear from these insightful papers
that the underlying tenet of patient-focused, oral healthcare team-delivery is applicable to all patients, at all stages of their lives, whether disease-active or in health. Indeed, the
underpinning strength of the MIOC framework domains is the continuity of care with underlying team-delivered communications to patients, to value and take responsibility of their own general
and oral health. This message has never been as pertinent and meaningful as it is now.9 MIOC UNDERPINS CARE THROUGHOUT THE LIFE-COURSE Dental caries is still one of the most prevalent
non-communicable diseases affecting humankind globally.10 There is clear need and benefit to have guidance as to how to deliver MIOC and MID to individuals, local regions and
country-specific populations. Of course, as all clinicians appreciate, there is always variation between practitioners as to how to resolve particular clinical challenges, with many, often
subjective, factors to be taken into account. To help in such instances, it is useful to have guidelines/standard operating protocols (SOPs) to help oral healthcare teams to manage their
patients. These cannot be restrictive rules and regulations; they should be a learned summation of the current, collated expert consensus, scientific and clinical evidence, however strong or
weak these may be, to be considered along with the individual patient, practitioner and local factors pertaining to each clinical scenario/patient and adapted accordingly.11 In this way,
each patient receives optimal care and the team/practitioner can feel confident in their approach and can also learn from others/add to their clinical experience and acumen, collectively.
The implementation of such consensus guidelines needs to be accompanied with careful communication and documentation between the team and patient of decisions made and the reasons as to why.
So, where are MI guidelines? What evidence, if any, should be considered, accepted or discarded?11 Which stakeholders are responsible for generating and updating them? How can guidelines be
validated locally, regionally, nationally or globally? Should there be nationwide/global coordination/training? There are many important guideline publications available for each of the
different disciplines in restorative dentistry, including periodontology, prosthodontics and endodontics. These often concentrate on standardising specific operative treatment protocols for
more clearly defined clinical situations. These are published by expert panels representing learned societies, royal colleges and government bodies. These groups are sometimes assisted by
industry partners to help convene the discussions. It is important, however, that industry partners do not influence the outcomes and these are kept strictly independent to avoid
inappropriate bias. > Through such adversity comes the glimmer of opportunity to change > and develop new strategies and mechanisms to deliver better oral > health programmes The
discipline of conservative & MI dentistry in primary care covers a great breadth and variety of clinical situations affecting a large, heterogeneous population. Many management variables
(technologies, procedures, materials, operator skills, knowledge, experience and a multitude of patient factors including attitudes/behaviour/socio-economic status etc) all need to be
considered when attempting to develop suitable treatment guidelines to help practitioners and their teams.12 Thanks to this complex interaction of variables, there is a relative paucity of
clear-cut, high quality evidence (for example, randomised controlled clinical trials) to enable such guidance to be absolute, conclusive and applicable to all scenarios. As an example of a
response to collate further high quality clinical evidence, the National Institute for Health Research UK (NIHR) is currently funding two national multi-centre primary care randomised
controlled trials, one on minimally invasive operative caries management - Selective Caries Removal in Permanent Teeth (SCRiPT), and the other on pulpotomy for the management of irreversible
pulpitis in mature teeth (PIP). These studies provide an exciting opportunity for NHS primary care dentists and their teams to get involved with 'real-life' clinical trial data
collection which will contribute to the evidence base to support advances in service provision (practice expenses are covered and eCPD awarded when participating in the trials - please email
[email protected] / [email protected] for further information about participation in these trials). In conservative & MI dentistry including endodontics, there are many national
and international learned societies and consensus panels, all providing useful information about the terminology, prevention and management of caries,13,14,15,16,17 toothwear18 and
management protocols for broken-down teeth. The European Federation of Conservative Dentistry (EFCD) and the European Organisation for Caries Research (ORCA) have collaborated in an attempt
to collate and generate pragmatic, evidence-based guidance for primary care practitioners.19,20,21,22,23 These, along with many other published efforts, are trying to help the relevant
stakeholders to manage patients, improve oral health linked to general health and increase awareness in populations of their role in valuing and taking responsibility for their personal
healthcare future.24,25 Education and training courses exist to help dentists, dental therapists and team members learn about and implement MIOC (for example, the online, distance-learning
master's programme in Advanced Minimum Intervention Dentistry). MIOC AND THE POST-PANDEMIC ERA A further consequence of the global COVID-19 pandemic is the generation of a multitude of
new terminologies and abbreviations. PPE (personal protective equipment for the general public at least), UDC (urgent dental care), furlough, AGP (aerosol generating procedure), AGE (aerosol
generating event), FFP2/3, BAPD (British Association of Private Dentistry), abatement, social distancing are a small selection of the professional terms now commonplace in our collective
vocabulary. But what about dentistry in the the post-pandemic era? As I mentioned at the beginning of this piece, few, if any, could predict the dramatic changes in global health and
economic outlook over the last few months and only time will tell as to how this manifests and moulds our new norms, personally, professionally and across broader society. However, through
such adversity comes the glimmer of opportunity to change and develop new strategies and mechanisms to deliver better oral health programmes for our patients. National and international
regulators will have to decide the new norms for social distancing at work, personal protective equipment and suitable infection prevention and control policies. Will the more limited use of
aerosol-generating procedures (AGPs) be encouraged beyond the short-term advice already actioned? Personalised preventive oral health advice via online, teledentistry delivery may, or
indeed should, become a funded aspect of primary care delivery, helping to evolve the relationship between 'oral health practices' and their patients. This may in turn improve the
reach and access to the more under-served parts of the population. I have been invited to assist the Office of the Chief Dental Officer in England in taking forwards the initiative to
develop and coordinate such clinical strategies and protocols, using these strange times as a once-in-a-lifetime opportunity to re-shape and augment the underlying clinical philosophy,
building on the MIOC framework across the dental disciplines to align this model of care with the phased recovery period. This should be accompanied by revised contracts and more agile NHS
commissioning while ensuring resilience of the approach through local peer support, enhanced team-delivery and training provision. Government messaging to the population will need to be more
balanced in this regard than ever before, where prevention, self-care, personal responsibility and awareness are given maximum priority in oral health promotion. Service providers,
regulators and the legal/indemnity profession will have to engage more in working together towards this common goal as opposed to the somewhat continued defensive, siloed, inward-focused
attitudes that still seem to prevail in times of greatest need. The maintenance of optimal oral health, inseparable from systemic health and physical/mental wellbeing, has never been so
important and at the forefront of people's minds and agendas. Suffice it to say, there is a hope that all stakeholders will finally start to value aspects of their own lives as well as
of those whom they represent that were once, perhaps, taken for granted. Maybe, just maybe, delivering better oral health through the MIOC framework may be one of those paradigm shifts for
the better.26 REFERENCES * Banerjee A. 'MI'opia or 20/20 vision? _Br Dent J_ 2013; 214: 101-105. * Banerjee A. 'Minimum intervention' - MI inspiring future oral
healthcare? _Br Dent J_ 2017; 223: 133-135. * Banerjee A, Doméjean S. The contemporary approach to tooth preservation: minimum Intervention (MI) caries management in general dental practice.
_Prim Dent J_ 2013; 2: 30-37. * Banerjee A. The contemporary practice of MID. _Faculty Dent J (RCS Eng)_ 2015; 6: 78-85. * Green D J, Mackenzie L, Banerjee A. Minimally invasive long term
management of direct restorations: the '5Rs'. _Dent Update_ 2015; 42: 413-426. * Martins B M d C, da Silva E J N L, Ferreir D M T P, Reis K R, Fidalgo T K d S. Longevity of
defective direct restorations treated by minimally invasive techniques or complete replacement in permanent teeth: A systematic review. _J Dent_ 2018; 78: 22-30. * Zebic L, Ezzeldin M, Patel
V _et al._ Caries prevention for children in a primary care setting - a collaborative clinical audit. _Br Dent J_ 2018; 224: 809-814. * Chana P, Orlans M.C, O'Toole S, Doméjean S,
Movahedi S, Banerjee A,. Restorative Intervention Thresholds and Treatment Decisions of General Dental Practitioners in London. _Br Dent J_ 2019; 227: 727-732. * Sculean A, Banerjee A,
Petersen P E. Editorial: Prevention and personal responsibility. _Oral Health Prev Dent_ 2016; 14: 3-4. * GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global,
regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global
Burden of Disease Study 2017. _Lancet_ 2019; 393: e44. * Sackett D L, Rosenberg W M C, Grey J A M, Haynes R B, Richardson W S. What is evidence-based medicine? _Br Med J_ 1996; 312: 71. *
Martignon S, Pitts N B, Goffin G _et al._ CariesCare Practice Guide: Consensus on Evidence into Practice. _Br Dent J_ 2019; 227: 353-362. * Schwendicke F, Frencken J E, Bjorndal L _et al._
Managing caries lesions: consensus recommendations on carious tissue removal. _Adv Dent Res_ 2016; 28: 58-67. * Innes N P T, Frencken J E, Bjorndal L _et al._ Managing caries lesions:
consensus recommendations on terminology. _Adv Dent Res_ 2016; 28: 49-57. * Machiulskiene V, Campus G, Carvalho J _et al._ Terminology of Dental Caries and Dental Caries Management:
Consensus Report of a Workshop Organized by ORCA and Cariology Research Group of IADR. _Caries Res_ 2020; 54: 7-14. * Banerjee A, Frencken J E, Schwendicke F, Innes N P T. Contemporary
operative caries management: consensus recommendations on minimally invasive caries removal. _Br Dent J_2017; 223: 215-222. * Duncan H F, Galler K M, Tomson P L _et al._ European Society of
Endodontology position statement: Management of deep caries and the exposed pulp. _Int Endod J_ 2019; 52: 923-934. * Toothwear-themed issue. _Br Dent J_ 2018 224. * Schwendicke F, Splieth C,
Breschi L _et al._ When to intervene in the caries process? An expert Delphi consensus statement. _Clin Oral Invest_ 2019; 23: 3691-3703. * Splieth C H, Banerjee A, Bottenberg P _et al_.
How to intervene in the caries process in children? A joint ORCA and EFCD expert Delphi consensus statement. _Caries Res_ 2020: DOI: 10.1159/000507692. * Splieth C H, Kanzow P, Wiegand A,
Schmoeckel J, Jablonski-Momeni A. How to intervene in the caries process: proximal caries in adolescents and adults - a systematic review and meta-analysis. _Clin Oral Invest_ 2020; 24:
1623-1636. * Schwendicke F, Splieth C H, Bottenberg P _et al._ How to intervene in the caries process in adults: Proximal and secondary caries? An EFCD-ORCA-DGZ expert Delphi consensus
statement. _Clin Oral Invest_ 2020; 24: 3315-3321. * Paris S, Banerjee A, Bottenberg P _et al._ How to intervene in the caries process in older adults? A joint ORCA and EFCD expert Delphi
consensus statement. _Caries Res_: In press. * Askar H, Krois J, Göstemeyer G _et al._ Secondary caries: What is it, and how can it be controlled, detected and managed? _Clin Oral Invest_
2020; 24: 1869-1876. * Costa R L, Bendo C B, Daher A _et al._ A curriculum for behaviour and oral healthcare management for dentally anxious children - recommendations from the Children
Experiencing Dental Anxiety: Collaboration on Research and Education (CEDACORE). _Int J Paed Dent_ 2020; 30: 556-569. * Hurley S. Why re-invent the wheel if you've run out of road?. _Br
Dent J_ 2020; 228: 755-756. Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Guest Editor BDJ Minimum Intervention Themed Issue and Professor of Cariology & Operative
Dentistry; Hon. Consultant, Restorative Dentistry; Head of Department, Conservative & MI Dentistry; Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, Guy’s
Dental Hospital, London, SE1 9RT, UK Avijit Banerjee Authors * Avijit Banerjee View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS
Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Banerjee, A. Minimum intervention oral healthcare delivery - is there consensus?. _Br Dent J_ 229, 393–395 (2020).
https://doi.org/10.1038/s41415-020-2235-x Download citation * Published: 09 October 2020 * Issue Date: October 2020 * DOI: https://doi.org/10.1038/s41415-020-2235-x SHARE THIS ARTICLE Anyone
you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by
the Springer Nature SharedIt content-sharing initiative
Trending News
Somatic and germline mutations in the tumor suppressor gene park2 impair pink1/parkin-mediated mitophagy in lung cancer cellsABSTRACT _PARK2_, which encodes Parkin, is a disease-causing gene for both neurodegenerative disorders and cancer. Parki...
Dangers of unexploded wwii munitions in north and baltic seas------------------------- * * X.com * Facebook * E-Mail * * * X.com * Facebook * E-Mail * Messenger * WhatsApp * Dieser ...
Metabolic make-up of nash: from fat and sugar to amino acidsNAFLD is regarded unquestionably as one of the components of the metabolic syndrome. Hence, metabolic perturbations occu...
Lw-213, a newly synthesized flavonoid, induces g2/m phase arrest and apoptosis in chronic myeloid leukemiaABSTRACT Chronic myeloid leukemia (CML) is a clonal hematopoietic stem cell neoplasm characterized by an uncontrolled pr...
Rifampicin induces clathrin-dependent endocytosis and ubiquitin–proteasome degradation of mrp2 via oxidative stress-activated pkc-erk/jnk/p38 and pi3kABSTRACT It was reported that antituberculosis medicines could induce liver damage via oxidative stress. In this study, ...
Latests News
Minimum intervention oral healthcare delivery - is there consensus?Firstly, I'd like to take this opportunity to offer all _BDJ_ readers my sincere best wishes in what has been a try...
Muscle cross-reinnervation (reply)Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ...
Individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosisABSTRACT The cysteine protease caspase-8 is an essential executioner of the death receptor (DR) apoptotic pathway. The p...
Inhibition of the activating signals in nk92 cells by recombinant gst-shla-g1α chainABSTRACT The soluble HLA-G1 (sHLA-G1) isoform was found to be secreted by trophoblast cells at the materno-fetal interfa...
Crizotinib treatment for refractory pediatric acute myeloid leukemia with ran-binding protein 2-anaplastic lymphoma kinase fusion geneCrizotinib is an anaplastic lymphoma kinase (ALK) inhibitor, which has brought marked clinical benefits to patients with...